EVA SIETSEMA: Open Payments
NPI 1831438944 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 17 payments from 8 companies in 2025. Trend: 2023 $627 · 2024 $372 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $70 |
| Lilly USA, LLC | 4 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Abbott Laboratories | 2 | $29 |
| ABBVIE INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| SANOFI PASTEUR INC. | 1 | $14 |
Products named: XIFAXAN, MOUNJARO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, VRAYLAR, ZEPBOUND, BEXSERO, SHINGRIX.
Industry payments across AZ — which companies pay providers there.
